Ceruletide

Jump to: navigation, search

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 266522473 | IUPAC_name = (3S)-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}-3-[(2S)-2-[(2S)-2-{2-[(3R)-2-[(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-{[(2S)-5-oxopyrrolidin-2-yl]formamido}butanamido]-3-carboxypropanamido]-3-[4-(sulfooxy)phenyl]propanamido]-3-hydroxybutanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]propanoic acid | image = Ceruletide.png

| tradename = | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref =  ☑Y | CAS_number = 17650-98-5 | ATC_prefix = V04 | ATC_suffix = CC04 | PubChem = 16219178 | DrugBank_Ref =  ☒N | DrugBank = DB00403 | ChemSpiderID_Ref =  ☒N | ChemSpiderID = 147304 | UNII_Ref =  ☒N | UNII = 888Y08971B | KEGG_Ref =  ☒N | KEGG = D03442 | ChEMBL_Ref =  ☒N | ChEMBL = 1201355

| C=58 | H=73 | N=13 | O=21 | S=2 | molecular_weight = 1352.40 g/mol }}

WikiDoc Resources for Ceruletide

Articles

Most recent articles on Ceruletide

Most cited articles on Ceruletide

Review articles on Ceruletide

Articles on Ceruletide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ceruletide

Images of Ceruletide

Photos of Ceruletide

Podcasts & MP3s on Ceruletide

Videos on Ceruletide

Evidence Based Medicine

Cochrane Collaboration on Ceruletide

Bandolier on Ceruletide

TRIP on Ceruletide

Clinical Trials

Ongoing Trials on Ceruletide at Clinical Trials.gov

Trial results on Ceruletide

Clinical Trials on Ceruletide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ceruletide

NICE Guidance on Ceruletide

NHS PRODIGY Guidance

FDA on Ceruletide

CDC on Ceruletide

Books

Books on Ceruletide

News

Ceruletide in the news

Be alerted to news on Ceruletide

News trends on Ceruletide

Commentary

Blogs on Ceruletide

Definitions

Definitions of Ceruletide

Patient Resources / Community

Patient resources on Ceruletide

Discussion groups on Ceruletide

Patient Handouts on Ceruletide

Directions to Hospitals Treating Ceruletide

Risk calculators and risk factors for Ceruletide

Healthcare Provider Resources

Symptoms of Ceruletide

Causes & Risk Factors for Ceruletide

Diagnostic studies for Ceruletide

Treatment of Ceruletide

Continuing Medical Education (CME)

CME Programs on Ceruletide

International

Ceruletide en Espanol

Ceruletide en Francais

Business

Ceruletide in the Marketplace

Patents on Ceruletide

Experimental / Informatics

List of terms related to Ceruletide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ceruletide (INN), also known as cerulein or caerulein, is a ten amino acid oligopeptide that stimulates smooth muscle and increases digestive secretions. Ceruletide is similar in action and composition to cholecystokinin. It stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle. It is used in paralytic ileus and as diagnostic aid in pancreatic malfunction. It is used to induce pancreatitis in experimental animal models.

File:Hyla caerula Korallen-Laubfrosch.jpg
The tree frog Litoria caerulae, formerly named Hyla caerulae.

Ceruletide was discovered and its structure elucidated in 1967 by Australian and Italian scientists from dried skins of the Australian green tree frog (Litoria caerulea, formerly Hyla caerulea). Its amino acid sequence is Pglu-Gln-Asp-Tyr[SO3H]-Thr-Gly-Trp-Met-Asp-Phe-NH2.[1][2]

Induction of pancreatitis

Ceruletide upregulates pancreatic acinar cell intercellular adhesion molecule-1 (ICAM-1) proteins through intracellular upregulation of NF-κB. Surface ICAM-1 in turn promotes neutrophil adhesion onto acinar cells enhancing pancreatic inflammation.[3] In addition to promoting the inflammatory cell reaction to acinar cells, ceruletide induces pancreatitis through dysregulation of digestive enzyme production and cytoplasmic vacuolization, leading to acinar cell death and pancreatic edema. Ceruletide also activates NADPH oxidase, a source of reactive oxygen species contributing to inflammation, as well as the Janus kinase/signal transducer, another inflammation inducer.[4]

See also

References

  1. A. Anastasi, V. Erspamer, and R. Endean (1967). "Isolation and structure of caerulein, an active decapeptide from the skin of Hyla caerulea". Experentia. 23 (9): 699–700. doi:10.1007/BF02154119.
  2. G. De Caro, R. Endean, V. Esparmer, and M. Roseghini (1968). "Occurrence of caerulein in extracts of the skin of Hyla caerulea and other Australian hylids". Br J of Pharmac Chemother. 33 (1): 48–58. PMC 1570274. PMID 5660165.
  3. V. Zaninovic, A. S. Gukovskaya, I. Gukovsky, M. Mouria and S. J. Pandol (2000). "Cerulein upregulates ICAM-1 in pancreatic acinar cells, which mediates neutrophil adhesion to these cells". Am J Physiol Gastrointest Liver Physiol. 279 (4): G666–676. PMID 11005752.
  4. H. Kim (2008). "Cerulein Pancreatitis: Oxidative Stress, Inflammation, and Apoptosis". Gut and liver. 167 (2): 74–80. doi:10.5009/gnl.2008.2.2.74. PMC 2871591. PMID 20485614.



Linked-in.jpg